Dr. Mohammad A. Al-Haddad, MD

Dr. Al-Haddad practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Al-Haddad's NPI, 1275516239, was assigned on November 23, 2005. Dr. Al-Haddad graduated from University of Jordan Faculty of Medicine in 1999. Dr. Al-Haddad's Indiana license number on file is 01062866A.

Dr. Al-Haddad's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Al-Haddad's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Al-Haddad is also affiliated with IU Health North Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Al-Haddad to 2 more group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Haddad practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Al-Haddad's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Al-Haddad is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Al-Haddad's licenses on file in 3 states: Indiana, Florida and Ohio.

Dmand AI lists acid reflux, colonoscopy and upper GI endoscopy among the conditions Dr. Al-Haddad treats.

CMS data shows 238 Medicare services from Dr. Al-Haddad across 10 procedure codes in 2024, for 188 Medicare patients. Medicare paid $35,363 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 188 Medicare patients who saw Dr. Al-Haddad in 2024. The largest group is 65 to 74, with 97 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Haddad's median patient age at 61, with 56% women.

In 2024, Dr. Al-Haddad wrote 464 Medicare Part D claims for 144 patients. 80% of them were for generic drugs. CMS names the drug for 326 of them, across 13 drugs with 11 or more claims each, at $178,241 in total drug cost. In 2023, CMS named 275 claims across 10 drugs.

Dr. Al-Haddad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 234 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Al-Haddad, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 195 papers to Dr. Al-Haddad, published from 2006 to 2025. 2023 was the busiest year, with 17. The most frequent topics are Endosonography, Pancreatic Neoplasms and Endoscopic Ultrasound-Guided Fine Needle Aspiration. Dr. Al-Haddad has published most often in Gastrointest Endosc. Dr. Al-Haddad's most frequent co-authors are Michael B. Wallace, MD, Sumant Inamdar, MBBS, MD, MPH and Massimo Raimondo, MD.

Dmand AI links Dr. Al-Haddad to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Bites and Stings, Esophageal Perforation and Gastroparesis. Indiana University sponsors the most, 3.

CMS Open Payments shows 118 general payments to Dr. Al-Haddad from 9 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $72,729.

Dr. Al-Haddad graduated from University of Jordan Faculty of Medicine in 1999.

Dr. Al-Haddad is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.